Compare STKE & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STKE | DRIO |
|---|---|---|
| Founded | 2002 | 2011 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.9M | 56.8M |
| IPO Year | 2021 | 2013 |
| Metric | STKE | DRIO |
|---|---|---|
| Price | $1.31 | $4.82 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $13.60 |
| AVG Volume (30 Days) | ★ 442.0K | 14.9K |
| Earning Date | 01-28-2027 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1559.02 |
| EPS | N/A | ★ 1.75 |
| Revenue | N/A | ★ $7,394,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $38.77 |
| P/E Ratio | ★ N/A | $2.93 |
| Revenue Growth | N/A | ★ 43.02 |
| 52 Week Low | $0.85 | $5.03 |
| 52 Week High | $3.95 | $16.50 |
| Indicator | STKE | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 42.92 | 31.44 |
| Support Level | $1.00 | N/A |
| Resistance Level | $1.37 | $8.01 |
| Average True Range (ATR) | 0.14 | 0.53 |
| MACD | -0.05 | -0.10 |
| Stochastic Oscillator | 9.02 | 2.48 |
Sol Strategies Inc is engaged in investing in blockchain technologies and crypto currencies. Company executes its Investment Objective through three lines of effort: Treasury management: Maintaining a core portfolio of cryptocurrencies for long-term growth, enhanced with risk management strategies to minimize volatility, and generating yield through lending, staking, and liquidity provisioning; Private equity focused on early stage companies in the DeFi and blockchain sectors; and Active investments to generate yield through strategic activities, including Bitcoin mining and stalking and validating Solana.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.